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Meditation techniques are increasinglypopular practices that maybe useful in preventing or reducing elevated blood pressure. We
reviewed landmark studies and recent literature concerning the use of meditation for reducing blood pressure in pre-hypertensive
and hypertensive individuals. We sought to highlight underlying assumptions, identify strengths and weaknesses of the research,
and suggest avenues for further research, reporting of results, and dissemination of ﬁndings. Meditation techniques appear to
produce small yet meaningful reductions in blood pressure either as monotherapy or in conjunction with traditional pharma-
cotherapy. Transcendental meditation and mindfulness-based stress reduction may produce clinically signiﬁcant reductions in
systolic and diastolic blood pressure. More randomized clinical trials are necessary before strong recommendations regarding the
use of meditation for high BP can be made.
1.Introduction:MeditationTechniquesas
TreatmentsforElevatedBlood Pressure
According to worldwide estimates, hypertension aﬀects ap-
proximately 1 billion people, resulting in 7.1 million attrib-
uted deaths per year [1]. In the United States, nearly half
of all adults have blood pressure (BP), expressed in terms
of systolic (SBP) over diastolic blood pressure (DBP), in the
prehypertensive(SBPof120–139orDBPof80–89)orhyper-
tensive (SBP > 140 or DBP > 90) range [2, 3]. As one of
the most widespread, least controlled diseases around the
world, hypertension poses a threat to adultsfrom all cultures
and lifestyles. Factors such as improved treatment, phar-
macologic interventions, preventativemeasures, and lifestyle
changes have contributed to a 60% decrease in age-adjusted
death rates from stroke and a 50% decrease in age-adjusted
death rates from coronary heart disease in the United States
since 1972. However, despite these improvements, BP con-
trol among American adults still remains suboptimal. For
example,two-thirdsofhypertensiveindividualsarenotbeing
controlled to recommended BP levels. Furthermore, approx-
imately 30% of American adults are unaware of their hyper-
tension, and over 40% of those with hypertension are not
receiving treatment [3].
Current treatment guidelines for hypertension include
antihypertensive medications and health-promoting lifestyle
modiﬁcations such as weight reduction, the DASH eating
plan (increased fruits and vegetables, and low fat dairy prod-
ucts with reduced saturated and total fat), reduced dietary
sodium, increased physical activity, and moderation of
alcohol consumption. Ideally, antihypertensive medications
and lifestyle modiﬁcations successfully reduce BP to optimal
levels. However, despite the eﬀectiveness of antihypertensive
medication [4], adherence to medication regimens is often
poor and interferes with the goal of reducing BP [5, 6]. In
addition, hypertensive medications can produce trouble-
some side eﬀects such as insomnia, sedation, dry mouth,
drowsiness, impotence, and headaches [4]. Due to diﬃculty2 International Journal of Hypertension
adhering, side eﬀects, and prescription drug costs, hyperten-
siveindividuals may desirea nonpharmacologic intervention
to avoid or complement their antihypertensive medication
regimen. Therefore, whereas continued improvement in
pharmacologic treatments is necessary, these advancements
must be complemented by nonpharmacological approaches
to BP control. Toward that end, mind-body interventions
such as relaxation, stress management, and meditation—
whether used alone or in combination with lifestyle mod-
iﬁcations—have been evaluated as potential treatments for
high BP (refer to Table 1 f o ra no v e r v i e wo ft h em a j o rt y p e s
of mind-body interventions). Ample evidence exists re-
garding the eﬀects of relaxation and stress management on
BP to draw some conclusions, which are discussed below.
However, less is known regarding the potential ofmeditation
as an intervention for hypertension. The purpose of this
focused paper is to evaluate the evidence that meditation is
an eﬀective intervention for lowering elevated BP (refer to
Table 2 for a summary of studies in the literature search).
2.Mind-Body Interventions
Relaxation therapies for hypertension have been evaluated
for over 30 years with disappointing results. For example,
the Hypertension Intervention Pooling Project found no
treatment eﬀect for SBP and a small eﬀect for DBP [22]. In
a study by Irvine and Logan, relaxation therapy produced
eﬀects equal to a group that received support therapy, and
the relaxation group did not produce a larger decrease in BP
[23]. Positive results sometimes observed for relaxation can
often be explained by methodology [24]; that is, individuals
with higher baseline BPs tend to beneﬁt more than individ-
uals with lower baseline BPs, and repeated monitoring of
BP appears suﬃcient to reduce BP levels [24, 25]. Overall,
relaxation techniques, the most common being progressive
muscle relaxation (PMR), are not considered eﬀective meth-
ods for treating hypertension [26]. Consequently, PMR can
even be used as a control group for randomized controlled
trials of other mind-body interventions.
In contrast, stress-management therapies have had some
success reducing BP [27–30]. In a meta-analysis, multicom-
ponent stress management treatments were more eﬀective in
reducing BP (13.5mm Hg SBP and 3.4mm Hg DBP) than
sham treatments, whereas single-component therapies (e.g.,
relaxation alone) did not produce signiﬁcant results [31].
Anothermeta-analysis reported thatmulticomponentstress-
management therapies were more eﬀective in reducing BP
than single-component relaxation-based therapies [32]. The
Canadian Coalition for High Blood Pressure Prevention and
Control has recommended multicomponent stress manage-
ment beconsidered for hypertensive individuals whose stress
appears to contribute to their hypertension [30].
Despite the promise of multicomponent stress-manage-
ment interventions, implementation has not been wide-
spread. Historically, the ﬁeld of behavioral medicine has
taken a keen interest in the contribution of stress to eleva-
tions in BP. Naturally, evidence that stress contributes to ele-
vated BP and hypertension was followed by attempts to treat
stress in order to reduce BP. However, stress-management
interventions for high BP are neither widely available nor
commonly practiced. Although we cannot be certain, we
speculate the association of stress management programs
with mental health treatment may introduce stigma and
reduce patientacceptanceofstress-management approaches.
The expense of treatment programs and relative scarcity of
healthcare professionals qualiﬁed to provide stress manage-
ment to patients with high BP may also contribute to the
limited implementation of multicomponent stress manage-
ment programs as a uniquely behavioral medicine solution
to hypertension.
Another mind-body intervention for high BP is medita-
tion. It appears to be a promising option, as meditation is
portable and can be practiced independently of structured
treatment programs, although evaluation in clinical trials
obviouslyrequiresacleartreatment protocol.Meditationhas
less associationwith mentalhealthstigma andmaybeamore
acceptable intervention than stress-management treatments
in many cultures.
The most widespread types of meditation interventions
can be roughly grouped into mantra meditation, such as
transcendental meditation (TM) and mindfulness medita-
tion. Mindfulness meditation involves an attitude of open-
ness, acceptance, and reﬂection rather than impulse and
judgment toward the practitioner’s current experiences, as
well as the observationof thoughts, feelings, and the external
world alike through calm, detached sensory awareness [33].
Mantra meditations focus on a word, phrase, or concept.
The mantras often have soft sounds, like “Om,” and these
words are thought toproducediﬀerentvibrationsindiﬀerent
people, producing various eﬀects on the individual [34]. In
the TM technique, the mantras, which are used for sound
value rather than meaning, become increasingly secondary
in experience and eventually disappear, while self-awareness
becomes primary in experience as the practitioner tran-
scends to a state of pure consciousness [35].
Mindfulness—described as a calm awareness of one’s
body, mind, and environment that embodies an interaction
between nonjudgmental acceptance and focuses on the pre-
sent moment—has existed for over 2,500 years and can
be found in numerous religions, cultures, meditation tech-
niques, and psychotherapies [36]. Although it is the 7th step
of the Noble Eightfold Path in Buddhism, there is noth-
ing inherently religious about mindfulness as it is mostly
taught completely independent from any religious doctrine.
Mindfulness meditation research became formalized in 1979
when Dr. Jon Kabat-Zinn founded the MBSR program at
University of Massachusetts-Amherst to treat the chronically
ill [37]. Other practices and interventions that utilize the
concept of mindfulness include yoga [38], acceptance and
commitment therapy [39], dialectical behavior therapy [40],
Tai Chi [41], and Qigong [42].
2.1. Transcendental Meditation. TM has been extensively
studied as a meditation therapy for high BP. In one study,
the feasibility and eﬃcacy of TM and progressive muscle
relaxation (PMR) were tested via a subgroup analysis by sex
and level of hypertension risk in older African Americans
[17]. Compared to control subjects who underwent lifestyleInternational Journal of Hypertension 3
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modiﬁcation education only, TM produced signiﬁcant de-
clines in BP after 3 months for both men (by 12.7mm Hg
SBP and 8.1mm Hg DBP) and women (by 10.4mm Hg SBP
and 5.9mm Hg DBP). In contrast, women practicing PMR
failed to show signiﬁcant declines, while men practicing
PMR experienced signiﬁcant declines solely in DBP (by
6.2mm Hg) [17]. An earlier randomized controlled trial of
TM by the same authors reported that 20 elderly patients
who were treated with TM exhibited a 12.4mm Hg drop in
SBP, compared to a 2.4mm Hg reduction for patients in the
control group [21].
The short-term eﬃcacy of TM and PMR in treating mild
hypertension was also evaluated in 127 African American
men and women aged 55 to 85 years, compared with a life-
style modiﬁcation education control program [18]. TM re-
duced SBP (10.7mm Hg) and DBP (4.7mm Hg), which
was signiﬁcantly greater than those observed for relaxation
(4.7mm Hg SBP and 3.3mm Hg DBP). Between the two
stress-reducing approaches, TM was about twice as eﬀective
as PMR. Later, Schneider and colleagues [19] conducted
anotherstudyfollowing AfricanAmericanhypertensive indi-
viduals over one year while they underwent TM, PMR, or
conventional health education classes as a control. The TM
group experienced greater decreases in SBP and DBP than
the PMR or control groups, as well as reduced use of anti-
hypertensive medication, relative to increases for PMR and
the control group. Consequently, the TM program may be
particularly useful in the long-term treatment of hyperten-
sion in African Americans, for whom many of these eﬀects
have been demonstrated. Schneider and colleagues also con-
ductedarecentmeta-analysis,which revealedthat,compared
with combined controls, the TM group showed substantial
decreases in all-cause mortality, cardiovascular mortality,
and cancer-related mortality [20].
In another study [16], unmedicated patients with hyper-
tension underwent TM-based training (treatment group),
TM-based training without a mantra (placebo control
group), or no training (no-treatment control group). Com-
pared with the no-treatment controls, modest BP declines
were observed in both the treatment and placebo control
groups, with DBP percentage showing a signiﬁcant decrease
[16]. The similarity in eﬀectiveness of TM training and TM
training without amantra couldbe attributedto the fact that
both were in eﬀect “meditation” groups or that changes in
BP were due to another factor. A meta-analysis that only
included high-quality assessments—as determined by 11
factors,whichincludedparticipantselection,randomization,
blinding,fulldescriptionofthetherapeuticintervention,and
appropriate measurements of BP—found TM, compared to
controls, associated with clinically meaningful reductions of
4.7 and 3.2mm Hg in SBP and DBP, respectively [43]. TM
hasalsoappearedtoreducecarotidarteriosclerosisinAfrican
Americans [12] and a 4.8mm Hg drop in ambulatory DBP
among white males treated with TM [13].
A study assessing the eﬀects of TM on BP, psychological
distress, and coping among university students was also
the ﬁrst randomized clinical trial to demonstrate that TM
signiﬁcantly increased coping and reduced BP in association
with lessened psychological distress in a hypertension risk
subgroup. The TM program may decrease the risk for devel-
oping hypertension in young adults [14]. TM also reduced
resting BP among adolescent African Americans with high
normal BP (with a resting SBP ≥85th and ≤95th percentile)
over two months, with larger declines than those in a health
education control group, demonstrated during both at rest
and during acute laboratory stressors [11]. In another study
on African American adolescents with high normal systolic
BP, the 4-month TM group showed greater declines in
daytime SBP (P<0.04) and DBP (P<0.06) compared
to the health education control group, further exhibiting a
beneﬁcial impact of TM in youth at risk for hypertension.
T h i ss t u d yi so fp a r t i c u l a ri n t e r e s td u et oi t su t i l i z a t i o no f
ambulatory 24-hour BP monitoring, which not only tends
to be relatively free of placebo eﬀects and to be highly
reproducible but also records BP regularly over a prolonged
time period in the participants’ natural environments, thus
increasing sensitivity to changes in average BP and providing
a more reliable measure of overall BP [15]. Ambulatory
studies like the one produced here by Barnes and colleagues
are valuable because they generate the potential to measure
treatment eﬀectsout of the laboratory and in day-to-day life,
which may allow generalization of treatment eﬀects.
2.2. MBSR. Mindfulness-based stress reduction (MBSR), a
subset of mindfulness meditation that has been standardized
and manualized, is said totreatdepression and anxiety,lower
stress, and treat health conditions like hypertension. MBSR
is a program that utilizes meditation and stress management
techniques. Originally founded by Dr. Jon Kabat-Zinn, The
Centerfor Mindfulness in Medicine, Health Care, and Socie-
ty at the University of Massachusetts Medical School (http://
www.umassmed.edu/cfm/) has treated over 19,000 patients
with MBSR.
MBSR was originally developed and used in a behavioral
medicine setting for individuals with chronic pain [44]a n d
typically consists of eight 2.5-hour weekly group sessions.
These sessions contain instruction and practice in mindful-
ness meditation, as well as conversations of stress, coping,
and homework assignments. Students learn a range of
mindfulness skillsincludingbodyscanexercises,sittingmed-
itation, and yoga exercises. Homework consists of practicing
these skills for at least 45 minutes per day, 6 days per week,
in addition to practicing mindfulness skills during group
meetings. The program concludes with an 8-hour intensive
mindfulness retreat with a therapist. During and after the
program, students are encouraged to pay mindful, non-
judgmental attention to daily activities like walking, eating,
and talking. One goal is for participants to see that most
sensations, emotions, and thoughts are short-lived and do
not require immediate suppression.
Recent studies have evaluated the eﬀectiveness of MBSR
for reducing BP, as well as breathing awareness meditation
(BAM), a primary exercise in MBSR, in producing declines
in BP among diﬀeringpopulations. Inonestudy, 121African
American ninth graders (with a resting SBP >50th percentile
and <95thpercentile) underwent BAM, life skills training, or
health education [8]. Among the three behavioral interven-
tion approaches, only BAM produced signiﬁcant decreases8 International Journal of Hypertension
in 24-hour SBP. Another study also conducted among 166
AfricanAmericanninthgradersatincreased risk foressential
hypertension compared the treatment eﬀects of BAM, the
Botvin LifeSkills Training, or a health education control [9].
Signiﬁcant group diﬀerences emerged, with the BAM group
exhibiting the greatest decreases in SBP, DBP, and heart rate.
MBSR has also shown some potential for lowering BP
in individuals with elevated BP. A recent study comparing
the eﬀects of MBSR versus PMR on prehypertensive adults
found that MBSR produced signiﬁcant reductions in SBP
and DBP. A 4.9mm Hg reduction in clinic SBP was observed
in the MBSR group compared to 0.7mm Hg in the PMR
group, and MBSR produced a 1.9mm Hg reduction in DBP
compared to a 1.2mm Hg increase for PMR [10]. The
resultswere qualitativelysimilartoreductionsinBPreported
in a meta-analysis of TM [45], as well as the reduction
observed in the PREMIER trial of comprehensive lifestyle
modiﬁcation for high BP [46]. In anotherstudy, adultfemale
posttreatment cancer patients who underwent MBSR did
not experience signiﬁcant diﬀerences in BP compared to
the waitlist control group [7]. However, when patients were
analyzed by “higher BP” and “lower BP” groups through a
median split based on BP readings during the ﬁrst week of
treatment, “higher BP” MBSR participants had lower SBP
compared to controls at the end of the MBSR program.
Given the normotensive sample and preliminary results due
to methodological limitations of the study (e.g., results may
have been an eﬀect of regression to the mean), more well-
designed trials are needed to evaluate the utility of MBSR in
reducing clinically elevated BP [7].
3.MethodologicalConsiderations
A report on meditation techniques conducted by the United
States Agency for Healthcare Research and Quality (AHRQ)
evaluated the methodological quality of 286 randomized
controlled trials employing meditation practices in a variety
of populations [33]. Studies were evaluated using the Jadad
scores, as the Jadad scale is the most commonly used assess-
ment scale of methodological quality of randomized con-
trolled trials in health care research [47]. Scores (on a scale
of 1–5, from lowest to highest methodological quality)
are based on reported method of randomization, double-
blinding, and description of withdrawals and dropouts, with
low scores indicating a higher risk of bias [48].The qualityof
meditation trials was evaluated to be poor overall, with only
14% being rated high quality (i.e., Jadad scores ≥3p o i n t s ) ;
the studiesreviewed were found to havetoo many qualitative
or observational reports, limited descriptions of participant
characteristics (including if the inclusion criteria required an
oﬃcial diagnosis of prehypertension or hypertension), small
sample sizes, inadequately described blinding procedures
and randomization, lack of control groups, insuﬃcient fol-
lowup periods, limited reporting of intention-to-treat statis-
tical analyses, and inadequately described losses to followup
[33]. Furthermore, much of the research published on spe-
ciﬁc forms of meditation has been conducted by the orga-
nizations that create or disseminate those speciﬁc forms of
meditation. Although the methodological quality of this re-
search is improving, meditation techniques should be tested
by independent research teams who haveno association with
organizations promoting a particular approach to medita-
tion. Recent additions to the literature have increasingly
adhered to the CONSORT recommendations (Consolidated
Standards of Reporting Trials; 49). There are many method-
ological improvements that can be made. For example,
conﬂict of interest and researcher bias can be minimized by
collaborative eﬀorts with outside institutions having inde-
pendent oversight of data collection and analysis, indepen-
dent replication, rigorous blinding, allocation concealment,
randomization, and selection of a suitable control condition.
4. FutureDirectionsand Studies
Future research targeting meditation interventions must be-
gin by adequately deﬁning the role of mindfulness or other
concepts and components in meditation and delineating
intentions for applications to the study population. Med-
itation treatments should be standardized and manualized
as much as possible to ensure maximal external validity.
Additionally, similarities and diﬀerences between kinds of
meditation interventions should be highlighted within pub-
lications. The role of mindfulness and meditation in a given
intervention should be explained. Furthermore, assessments
that target measurements of the construct, mindfulness, and
the process through which mindfulness is achieved, medi-
tation, should be reﬁned and psychometrically validated in
medical populations and healthy controls.
Future studies should clearly outline their inclusion and
exclusioncriteria,witheﬀortstoextendmeditationinterven-
tions to hypertensive individuals who otherwise belong to
understudiedpopulations.Includingavarietyofpopulations
makes the examination of potential moderators such as
ethnicity possible. Aims should include using larger sample
sizes and continuing with the disease-speciﬁc approach to
interventions, implying the use of strict inclusion criteria
requiring participants must be diagnosed with either prehy-
pertension or hypertension to participate. There may need
to be a better selection of control protocols, with preference
given to similar interventions that have been validated to
not produce the results experimenters expect to ﬁnd (or
not) in the experimental condition. In addition, studies
deﬁning dose response would be substantially beneﬁcial in
helping not only to conﬁrm the correlation-eﬀect link, but
also to determine how much of an intervention produces
both statistically and clinically signiﬁcant eﬀects. This would
facilitate wider dissemination and scalability.
Proceduralandstatisticalmethodologymustbeexplicitly
outlined so the studies can be critiqued and replicated and
so articles published from the studies can be included in
reviews and meta-analyses. With improved adoption of the
CONSORTguidelines[49],bettersystematic comparisons of
eﬀects of diﬀerent mindfulness interventions can be estab-
lished. Hopefully, as the methodology and reporting of these
studies is strengthened and clariﬁed, scientists will be able to
adopt more experimental designs, ultimately optimizing the
ability to make causal inferences.International Journal of Hypertension 9
Meditation is an intervention for hypertension and pre-
hypertension that is perhaps best characterized as being in
its adolescence. There is clearly considerable promise, with a
variety of studies demonstrating eﬃcacy in the short-term
reduction of BP similar to that achieved with single-agent
drug therapy. On the other hand, many of these studies
are potentially biased due to lack of blinding, inadequate
baseline measurements ofBP, and limited followup. Allmed-
itationtechniquesare notcreated equal,and few studieshave
directly compared one technique to another. More impor-
tantly, there has been essentially no evaluation to determine
what may be the essential components of a putatively suc-
cessful methodology or if an entire “standard” approach is
required. This has major implications for scalability, partic-
ularly in resource-limited settings where both clinical staﬀ
time and patient meditation environment and time may
be constrained. Hypothesis-driven mechanistic studies are
rare and, if well conceived and executed, could dramat-
ically advance the ﬁeld. Potential mechanisms of action
include alterations in the autonomic nervous system, with
changes in the sympathovagal balance favoring the latter.
Perhaps meditation aﬀects mood in hypertensives; in other
settings depression has been associated with physical inac-
tivity and altered eating patterns, both of which may aﬀect
BP.
Hypertension is paradigmatic of a chronic disease, with
clinical sequelae typically developing after years of elevated
BP. Long-term followup, after the acute intervention is com-
pletebut,while thepatientis still employingmeditative tech-
niques, is essential. Perhaps “booster doses” of instruction
will be required. While prima facie meditation would appear
to be free of side eﬀects, few studies have systematically
evaluated their presence and consequences. It is possible that
the most signiﬁcant side eﬀect may be procedural, where
meditation is simplistically viewed only as an alternative or
substitute for antihypertensive drugs. Pharmacotherapy of
hypertension frequently involvesmultiple drugs, particularly
in those with substantially elevated baseline pressure. It is
unlikely that meditation will be eﬀective as monotherapy in
all (and perhaps most of) patients with established hyper-
tension. Atherapeuticapproach ofmultimodality treatment,
wherein meditation is truly viewed as complementary to
drug treatment, is an important underexplored area, with
the potential to expand the number of individuals who
could both beneﬁt from meditative techniques and achieve
improved BP control.
Perhaps the greatest potential beneﬁts of meditation
techniquesin the treatment of individuals with hypertension
are in developing countries. Many of these countries are
experiencing large population growth and with the increas-
ing penetration of a Western lifestyle come both increased
caloric and sodium intake and decreased physical activity.
In these circumstances, cardiovascular diseases, particularly
hypertension, areassuming increasedprevalence.Meditation
techniques, if they can be delivered eﬃciently and eﬀectively,
may prove to be valuable tools to treat the growing epidemic
of hypertension, particularly if they eliminate the inconve-
niences of laboratory monitoring or prescription reﬁlls and
indeed have few and rare side eﬀects.
Itisourhopethatthisoverviewofmeditation techniques
has highlighted prior successes, outlinedthe limitations exis-
tent in the ﬁeld today and provided inspiration and guidance
to move the ﬁeld forward with mechanistic, speciﬁcally
detailed, and long-term studies in the future.
Considering the current healthcare system in the United
States, it is possible for mindfulness interventions to be
implemented as both prevention and treatment programs
(pending conﬁrmation of their eﬀectiveness). Most mindful-
ness interventions can be taught in a group format, which
reducesthecostonparticipantsandtheburdenonclinicians.
As more treatments are standardized and their eﬃcacy can
be demonstrated in clinical trials, insurance companies may
be more inclined to fund mindfulness training. Longitudinal
studies must also be executed to determine if mindfulness
can act as a protective factor against an array of psychosocial
and medical ailments. Positive results may indicate that
mindfulness interventions could produce a clinically signiﬁ-
cant resiliency or protection against problems requiring care
from mental health and medical professionals. As a promis-
ing construct in complementary and alternative medicines,
there is a strong possibility that mindfulness could become
a component of eﬀective interventions designed to prevent
hypertension and lower suboptimal BP.
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